---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042592"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2026-09-14T20:35:23+00:00"
generated_at: "2026-09-14T20:37:08.314251+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech converts $400K debt to 1.75M shares at $0.228 per share

## Summary
- Converted $400,000 of Nov 18, 2025 promissory note into 1,749,434 shares at avg $0.228/share via two exchange agreements.
- Shares issued to Streeterville Capital under Section 3(a)(9) exemption; no cash consideration; reduces outstanding note balance.
- Stockholders approved conversion at July 15, 2026 special meeting per NYSE American Company Guide Sections 713(a)/(b).
- Original note principal $3,301,250; remaining balance outstanding after conversion.

## SEC filing metadata
- accession: 0001493152-26-042592
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2026-09-14T20:35:23+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315226042592/0001493152-26-042592-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315226042592/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042592
- JSON: https://secwatch.observer/filing/0001493152-26-042592.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042592.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.